NLRP3 Cancer Research Results
NLRP3, NOD-like receptor pyrin domain-containing protein 3: Click to Expand ⟱
| Source: |
| Type: |
NLRP3 (NOD-like receptor pyrin domain-containing protein 3) is a protein that plays a crucial role in the regulation of inflammation and immune responses.
NLRP3 typically has high expression in cancers, with poor prognosis.
For alzheimer's disease:
-NLRP3 is upregulated in Alzheimer's disease (AD)
-NLRP3 is activated in microglia in response to amyloid-β (Aβ) and tau aggregates.
-Promotes tau hyperphosphorylation and spread via inflammation-driven pathways.
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*TMAO↑, *ROS↑, *NADPH↑, *Ca+2↑, *AntiAg↓, *cognitive↓, *TJ↓, *CLDN1↓, *ZO-1↓, *Inflam↑, *NLRP3↑, *ER Stress↑, *cognitive↓, *Dose↝, *eff↑, *other↝, *other↝, *other↝,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *hepatoP↑, *neuroP↑, *AntiCan↑, *toxicity↝, *BioAv↓, *HO-1↑, *NRF2↑, *NLRP3↑, *SOD↑, *SOD1↑, *ROS↓, *AntiAge↑, *ARE↑, *STAT↓, *NF-kB↓, *neuroG↑, *memory↑, ROS↑, NLRP3↑, CIP2A↓, Akt↓, STAT3↑, VEGFR2/KDR/Flk1↓, DNMTs↓, MAPK↓, YAP/TEAD↓, PI3K↓, Wnt↓, NOTCH↓, TumCCA↑, TumCG↓, TumCP↓, FAK↑, MMP9↓, TumAuto↑, toxicity↝, BioAv↓, Half-Life↝, BioAv↑, selectivity∅,
*Inflam↓, *antiOx↑, *ROS↓, *NLRP3↑, *NF-kB↓, *SOD↑, *Catalase↑, *AntiAg↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*BioAv↝, *cardioP↑, *Obesity↓, *neuroP↑, *toxicity↝, *Dose↝, *GutMicro↑, *AMPK↑, *glucose↓, *NLRP3↑, *Inflam↓, *Stroke↓, *Cartilage↑, FOXP3↑, TumAuto↑, mTOR↓, PD-L1↓, RadioS↑, ChemoSen↑, ROS↓, OXPHOS↓, compI↓, Glycolysis↝, TumCP↓, *BioAv↝, *AntiAge↑, *SIRT1↑, *cognitive↑, *Risk↓, Ki-67↓, Synergy↝, PFS∅, OS∅,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↓, 1, ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
compI↓, 1, OXPHOS↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
Glycolysis↝, 1,
Cell Death(tgid=5) ⓘ
YAP/TEAD↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 1, CIP2A↓, 1, MAPK↓, 1, mTOR↓, 1, PI3K↓, 1, STAT3↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
DNMTs↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 2,
Cell Cycle & Senescence(tgid=11) ⓘ
Ki-67↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Ki-67↓, 1, NOTCH↓, 1, TumCG↓, 1, TumCP↓, 2, Wnt↓, 1,
Migration(tgid=13) ⓘ
FAK↑, 1, MMP9↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
VEGFR2/KDR/Flk1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
FOXP3↑, 1, NLRP3↑, 1, PD-L1↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 1, Half-Life↝, 1, RadioS↑, 1, selectivity∅, 1, Synergy↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
PD-L1↓, 1,
Functional Outcomes(tgid=23) ⓘ
OS∅, 1, PFS∅, 1, toxicity↝, 1,
Total Targets: 38
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, ARE↑, 1, Catalase↑, 1, HO-1↑, 1, NRF2↑, 1, ROS↓, 2, ROS↑, 1, SOD↑, 2, SOD1↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, glucose↓, 1, NADPH↑, 1, SIRT1↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
STAT↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 3,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
neuroG↑, 1,
Migration(tgid=13) ⓘ
AntiAg↓, 1, AntiAg↑, 1, Ca+2↑, 1, Cartilage↑, 1,
Barriers & Transport(tgid=15) ⓘ
CLDN1↓, 1, TJ↓, 1, ZO-1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 3, Inflam↑, 1, NF-kB↓, 2, NLRP3↑, 4,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↝, 2, Dose↝, 2, eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
TMAO↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 2, AntiCan↑, 1, cardioP↑, 1, cognitive↓, 2, cognitive↑, 1, hepatoP↑, 1, memory↑, 1, neuroP↑, 2, Obesity↓, 1, Risk↓, 1, Stroke↓, 1, toxicity↝, 2,
Infection & Microbiome(tgid=24) ⓘ
GutMicro↑, 1,
Total Targets: 46
Scientific Paper Hit Count for: NLRP3, NOD-like receptor pyrin domain-containing protein 3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:908 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page